Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Drugs alphabetical "e", total number of products: 481
Reg.‑No.
Product
Composition
A
|
B
|
C
|
D
|
E
|
F
|
G
|
H
|
I
|
J
|
K
|
L
|
M
|
N
|
O
|
P
|
Q
|
R
|
S
|
T
|
U
|
V
|
W
|
X
|
Y
|
Z
|
0-9
1 - 100
101 - 200
201 - 300
301 - 400
401 - 481
60568
IP
CI
Eloine
Coated tablets: 2 Active Agents
G
44644
IP
CI
Elotrans
Soluble Powder: 4 Active Agents
G
57207
IP
Eloxatine 100 mg/20 ml
Concentrate for infusion: Oxaliplatinum 100mg / 20ml
G
57207
IP
Eloxatine 200 mg/40 ml
Concentrate for infusion: Oxaliplatinum 200mg / 40ml
G
57207
IP
Eloxatine 50 mg/10 ml
Concentrate for infusion: Oxaliplatinum 50mg / 10ml
G
69990
Eltrombopag Accord 12.5 mg
Coated tablets: Eltrombopagum 12.5 mg
G
69990
Eltrombopag Accord 25 mg
Coated tablets: Eltrombopagum 25 mg
G
69990
Eltrombopag Accord 50 mg
Coated tablets: Eltrombopagum 50 mg
G
69990
Eltrombopag Accord 75 mg
Coated tablets: Eltrombopagum 75 mg
G
69450
Eltrombopag NOBEL 12.5 mg
Coated tablets: Eltrombopagum 12.5 mg
G
69450
Eltrombopag NOBEL 25 mg
Coated tablets: Eltrombopagum 25 mg
G
69450
Eltrombopag NOBEL 50 mg
Coated tablets: Eltrombopagum 50 mg
G
69450
Eltrombopag NOBEL 75 mg
Coated tablets: Eltrombopagum 75 mg
G
29812
IP
CI
Eltroxin-LF, 0.05 mg
Tablets: Levothyroxinum Natricum Anhydricum 50 µg
G
29812
IP
CI
Eltroxin-LF, 0.1 mg
Tablets: Levothyroxinum Natricum Anhydricum 100 µg
G
69037
IP
Elucirem 0.5 mmol/ml
G
68791
IP
Elucirem 0.5 mmol/ml
G
63023
IP
CI
Elvanse 20 mg
Capsules: Lisdexamfetamini Dimesilas 20 mg
G
63023
IP
CI
Elvanse 30 mg
Capsules: Lisdexamfetamini Dimesilas 30 mg
G
63023
IP
CI
Elvanse 40 mg
Capsules: Lisdexamfetamini Dimesilas 40 mg
G
63023
IP
CI
Elvanse 50 mg
Capsules: Lisdexamfetamini Dimesilas 50 mg
G
63023
IP
CI
Elvanse 60 mg
Capsules: Lisdexamfetamini Dimesilas 60 mg
G
63023
IP
CI
Elvanse 70 mg
Capsules: Lisdexamfetamini Dimesilas 70 mg
G
61655
IP
CI
Elyfem 20
Dragées: 2 Active Agents
G
61656
IP
CI
Elyfem 30
Dragées: 2 Active Agents
G
69020
IP
CI
Elymbus 0.1 mg/g
G
68797
IP
Elzonris 1mg / ml
Concentrate for infusion: Tagraxofuspum 1 mg/ml
G
56060
IP
CI
Emadine SE
Eye drops: Emedastinum
G
54881
IP
CI
Emadine
Eye drops: Emedastinum
G
53260
IP
CI
Emedrin N
Sirup: Dextromethorphanum 12.5mg / 5ml
G
56359
IP
CI
Emend 125 mg
Capsules: Aprepitantum 125 mg
G
56359
IP
CI
Emend 80 mg
Capsules: Aprepitantum 80 mg
G
67620
IP
CI
Emerade 150 ug
Injektionslösung im Fertigpen: Adrenalinum 150µg / 0.15ml
G
67620
IP
Emerade 300 ug
Injektionslösung im Fertigpen: Adrenalinum 300µg / 0.3ml
G
67620
IP
Emerade 500 ug
Injektionslösung im Fertigpen: Adrenalinum 500µg / 0.5ml
G
67026
IP
CI
Emgality 120 mg
Injection solution in prefilled syringe: Galcanezumabum 120 mg/ml
G
68556
Emge Biomed
Pulver zur Herstellung einer Lösung zum Einnehmen: Magnesium 300 mg
G
52980
IP
CI
Emla Patch
Patch: 2 Active Agents
G
46850
IP
CI
Emla
Cream: 2 Active Agents
G
43142
IP
CI
Emovate
Cream: Clobetasoni-17 Butyras
G
65920
IP
Empliciti 300 mg
Lyophilisate: Elotuzumabum 300 mg
G
65920
IP
Empliciti 400 mg
Lyophilisate: Elotuzumabum 400 mg
G
66180
IP
Empressin
Concentrate for infusion: Argipressinum 40U.I. / 2ml
G
56871
IP
CI
Emselex 15 mg
Delayed release tablets: Darifenacinum 15 mg
G
56871
IP
CI
Emselex 7.5 mg
Delayed release tablets: Darifenacinum 7.5 mg
G
10167
IP
CI
Emser Salz
15 Active Agents
G
66181
IP
CI
Emtricitabin-Tenofovir-Mepha
Coated tablets: 2 Active Agents
G
67010
IP
CI
Emtricitabin/Tenofovir Viatris
Coated tablets: 2 Active Agents
G
56880
IP
CI
Emtriva
Capsules: Emtricitabinum 200 mg
G
68915
IP
CI
Emylif 50 mg
film orodispersibile: Riluzolum 50 mg
G
56499
IP
CI
Enalapril HCT Zentiva
Tablets: 2 Active Agents
G
62149
IP
CI
Enalapril Spirig HC 10 mg
Tablets: Enalaprili Maleas 10 mg
G
62149
IP
CI
Enalapril Spirig HC 20 mg
Tablets: Enalaprili Maleas 20 mg
G
62149
IP
CI
Enalapril Spirig HC 5 mg
Tablets: Enalaprili Maleas 5 mg
G
58866
IP
CI
Enalapril-HCT-Mepha
Tablets: 2 Active Agents
G
63264
IP
CI
Enalapril-Mepha 10 mg
Tablets: Enalaprili Maleas 10 mg
G
63264
IP
CI
Enalapril-Mepha 20 mg
Tablets: Enalaprili Maleas 20 mg
G
63264
IP
CI
Enalapril-Mepha 5 mg
Tablets: Enalaprili Maleas 5 mg
G
11909
IP
Enavive
Injection solution: Dexpanthenolum 500mg / 2ml
G
57711
IP
CI
Enbrel 25 mg
Injection solution in prefilled syringe: Etanerceptum 25mg / 0.5ml
G
69740
Enbrel 25 mg
Injection solution in prefilled syringe: Etanerceptum 25 mg/ml
G
55365
IP
CI
Enbrel 25 mg
Lyophilisate and solvent: Etanerceptum 25 mg
G
57711
IP
CI
Enbrel 50 mg
Injection solution in prefilled syringe: Etanerceptum 50 mg/ml
G
60025
IP
CI
Enbrel MyClic 50 mg
Injektionslösung im Fertigpen: Etanerceptum 50 mg/ml
G
00628
IP
Encepur N Kinder
Injection suspension: Virus fsme Inactivatus (Stamm K23) 0.75µg / 0.25ml
G
00627
IP
CI
Encepur N
Injection suspension: Virus fsme Inactivatus (Stamm K23) 1.5µg / 0.5ml
G
25442
IP
CI
Endoxan 1 g
Lyophilisate: Cyclophosphamidum Anhydricum 1000 mg
G
25442
IP
CI
Endoxan 200 mg
Dry substance: Cyclophosphamidum Anhydricum 200 mg
G
25442
IP
CI
Endoxan 500 mg
Dry substance: Cyclophosphamidum Anhydricum 500 mg
G
25441
IP
CI
Endoxan
Dragées: Cyclophosphamidum Anhydricum 50 mg
G
67596
IP
CI
Enerzair Breezhaler 150/50/160 μg
G
00551
IP
Engerix-B 10
Injection suspension: Hepatitidis b viri Antigenum Adnr 10µg / 0.5ml
G
00534
IP
Engerix-B 20
Injection suspension: Hepatitidis b viri Antigenum Adnr 20 µg/ml
G
41436
CI
Engystol N
Injection solution: 2 Active Agents
G
52651
Engystol
Tablets: 2 Active Agents
G
67967
IP
Enhertu 100 mg
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum Deruxtecanum 100 mg
G
68074
IP
Enjaymo 1100 mg/22 ml
Infusion solution: Sutimlimabum 50 mg/ml
G
69073
IP
Enrylaze 10 mg/vial
Injection solution: Crisantaspasum 10mg / 0.5ml
G
67617
IP
CI
Enspryng 120 mg
Injektionslösung zur subkutanen Anwendung: Satralizumabum 120 mg/ml
G
65893
IP
CI
Enstilar
Schaum zur Anwendung auf der Haut: 2 Active Agents
G
65307
IP
CI
Entacapon Plus Sandoz 100/25/200 mg
Coated tablets: 3 Active Agents
G
65307
IP
CI
Entacapon Plus Sandoz 125/31.25/200 mg
Coated tablets: 3 Active Agents
G
65307
IP
CI
Entacapon Plus Sandoz 150/37.5/200 mg
Coated tablets: 3 Active Agents
G
65307
IP
CI
Entacapon Plus Sandoz 200/50/200 mg
Coated tablets: 3 Active Agents
G
65307
IP
CI
Entacapon Plus Sandoz 50/12.5/200 mg
Coated tablets: 3 Active Agents
G
65307
IP
CI
Entacapon Plus Sandoz 75/18.75/200 mg
Coated tablets: 3 Active Agents
G
66449
IP
CI
Entecavir Sandoz 0.5 mg
Coated tablets: Entecavirum
G
66449
IP
CI
Entecavir Sandoz 1 mg
Coated tablets: Entecavirum 1 mg
G
66709
IP
CI
Entecavir-Mepha 0.5mg
Coated tablets: Entecavirum
G
66709
IP
Entecavir-Mepha 1.0mg
Coated tablets: Entecavirum 1 mg
G
53305
IP
CI
Entocort CIR 3 mg
Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg
G
52042
IP
CI
Entocort Enema
Enema: Budesonidum 2.3 mg
Enema: Budesonidum 2mg / 100ml
G
57574
IP
Entonox
Gas zur medizinischen Anwendung: 2 Active Agents
G
65673
IP
CI
Entresto 100 mg
Coated tablets: 2 Active Agents
G
69255
IP
Entresto 15 mg/16 mg
filmüberzogenes Granulat: 2 Active Agents
G
65673
IP
CI
Entresto 200 mg
Coated tablets: 2 Active Agents
G
65673
IP
CI
Entresto 50 mg
Coated tablets: 2 Active Agents
G
69255
IP
CI
Entresto 6 mg/6 mg
filmüberzogenes Granulat: 2 Active Agents
G
33639
IP
CI
Entumin 40 mg
Tablets: Clotiapinum 40 mg
G
67534
IP
CI
Entyvio subkutan 108 mg
Injektionslösung in einem Fertigpen: Vedolizumabum 108mg / 0.68ml
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home